PPARα Ligand WY14643 Reduced Acute Rejection After Rat Lung Transplantation With The Upregulation of IL-4, IL-10 and TGFβ mRNA Expression

Journal of Heart and Lung Transplantation

Volumn 28, Issue 11, 2009, Pages 1172-1179

  Yanagisawa, Jun ^a   Shiraishi, Takeshi ^a   Iwasaki, Akinori ^a   Maekawa, Shinichi ^a   Higuchi, Takao ^a   Hiratuka, Masafumi ^a   Tanaka, Toshihiro ^a   Shibaguchi, Hirotomo ^a   Kuroki, Masahide ^a   Shirakusa, Takayuki ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; PIRINIXIC ACID; TRANSFORMING GROWTH FACTOR BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PYRIMIDINE DERIVATIVE;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; GENE EXPRESSION REGULATION; GRAFT RECIPIENT; GRAFT SURVIVAL; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; RAT; SPLEEN; SURVIVAL TIME; UPREGULATION; ANIMAL; BROWN NORWAY RAT; FISCHER 344 RAT; GENETICS; GRAFT REJECTION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; GRAFT REJECTION; INTERLEUKIN-10; INTERLEUKIN-4; LUNG TRANSPLANTATION; PPAR ALPHA; PYRIMIDINES; RATS; RATS, INBRED BN; RATS, INBRED F344; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 70350044392     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.06.016     Document Type: Article

References (35)

1. Trulock E.P., Christie J.D., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 26 (2007) 782-795
2. Sharples L.D., McNeil K., Stewart S., et al. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 21 (2002) 271-281
3. Dallman M.J. Cytokines as mediators of organ graft rejection and tolerance. Curr Opin Immunol 5 (1993) 788-793
4. Takeuchi T., Lowry R.P., and Konieczny B. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 53 (1992) 1281-1294
5. Plain K.M., Fava L., Spinelli A., et al. Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of TH2 cytokines. Transplantation 64 (1997) 1559-1567
6. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895
7. Issemann I., Prince R.A., Tugwood J.D., et al. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol 11 (1993) 37-47
8. Chinetti G., Griglio S., Antonucci M., et al. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273 (1998) 25573-25580
9. Cunard R., Ricote M., DiCampli D., et al. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J Immunol 168 (2002) 2795-2802
10. Marx N., Kehrle B., Kohlhammer K., et al. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res 90 (2002) 703-710
11. Lovett-Racke A.E., Hussain R.Z., Northrop S., et al. Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. J Immunol 172 (2004) 5790-5798
12. Maruyama S., Kato K., Kodama M., et al. Fenofibrate, a peroxisome proliferator-activated receptor alpha activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats. J Atheroscler Thromb 9 (2002) 87-92
13. Lee J.W., Bajwa P.J., Carson M.J., et al. Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. Gastroenterology 133 (2007) 108-123
14. Prop J., Wagenaar-Hilbers J.P., Petersen A.H., et al. Diagnosis of rejection in rat lung allografts by bronchoalveolar lavage. Transplant Proc 19 (1987) 3779-3780
15. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 15 (1996) 1-15
16. Cherwinski H.M., Schumacher J.H., Brown K.D., et al. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 166 (1987) 1229-1244
17. Ross D.J., Moudgil A., Bagga A., et al. Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage. J Heart Lung Transplant 18 (1999) 627-636
18. Takeuchi T., Ueki T., Sunaga S., et al. Murine interleukin 4 transgenic heart allograft survival prolonged with down-regulation of the Th1 cytokine mRNA in grafts. Transplantation 64 (1997) 152-157
19. Bromberg J.S. IL-10 immunosuppression in transplantation. Curr Opin Immunol 7 (1995) 639-643
20. He X.Y., Chen J., Verma N., et al. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses. Transplantation 65 (1998) 1145-1152
21. Moore K.W., de Waal Malefyt R., Coffman R.L., et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
22. Shinozaki K., Yahata H., Tanji H., et al. Allograft transduction of IL-10 prolongs survival following orthotopic liver transplantation. Gene Ther 6 (1999) 816-822
23. Hong Y.S., Laks H., Cui G., et al. Localized immunosuppression in the cardiac allograft induced by a new liposome-mediated IL-10 gene therapy. J Heart Lung Transplant 21 (2002) 1188-1200
24. Itano H., Mora B.N., Zhang W., et al. Lipid-mediated ex vivo gene transfer of viral interleukin 10 in rat lung allotransplantation. J Thorac Cardiovasc Surg 122 (2001) 29-38
25. Li M.O., Wan Y.Y., Sanjabi S., et al. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24 (2006) 99-146
26. Kehrl J.H. Transforming growth factor-beta: an important mediator of immunoregulation. Int J Cell Cloning 9 (1991) 438-450
27. Li M.O., Sanjabi S., and Flavell R.A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25 (2006) 455-471
28. Chen W., Jin W., Hardegen N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
29. Strom T.B., Roy-Chaudhury P., Manfro R., et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 8 (1996) 688-693
30. Oishi H., Okada Y., Kikuchi T., et al. Lipid-mediated transbronchial human interleukin-10 gene transfer decreases acute inflammation associated with allograft rejection in a rat model of lung transplantation. Transplant Proc 39 (2007) 283-285
31. Stephany B.R., Alao B., Budev M., et al. Hyperlipidemia is associated with accelerated chronic kidney disease progression after lung transplantation. Am J Transplant 7 (2007) 2553-2560
32. Silverborn M., Jeppsson A., Martensson G., et al. New-onset cardiovascular risk factors in lung transplant recipients. J Heart Lung Transplant 24 (2005) 1536-1543
33. Kobashigawa J.A. Statins in solid organ transplantation: is there an immunosuppressive effect?. Am J Transplant 4 (2004) 1013-1018
34. Paumelle R., Blanquart C., Briand O., et al. Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway. Circ Res 98 (2006) 361-369
35. Graham D.J., Staffa J.A., Shatin D., et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 292 (2004) 2585-2590